← All trials
NCT05200559
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2022
- Primary completion
- Dec 31, 2025
- Completion date
- Dec 31, 2027
- First posted
- Jan 20, 2022
- Last posted
- Oct 5, 2022
- Enrollment
- 70
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of PittsburghLead sponsor
- University of PittsburghOverall official - principal investigator
- University of PittsburghSponsor investigator
- Dr. Reddy's LaboratoriesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.